// App-Quantinova.ai

11027 : Subclassification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases.

Researchers

Presenter

  • Yi-Tsung Lu

Principal Investigators

  • Jie-Fu Chen

  • Ker-Chau Li

  • Zunfu Ke

  • Hsian-Rong Tseng

  • Edwin M. Posadas

  • Hao Ho

  • Jake Lichterman

  • Leland WK Chung

Medical Centers

  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Encino, CA

  • Institute of Statistical Sciences, Academia Sinica, Taipei, TaiwanDepartment of Molecular and Medical Pharmocology, University of California, Los Angeles, Los Angeles, CADepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

  • Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, Los Angeles, CA

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved